A new study has identified a mechanism used by tumors to recruit stem cells from bone and convert them into cancer-associated fibroblasts (CAFs) that facilitate tumor progression. This work, which pinpoints the specific biochemical ...
Oct 20, 2016
0
1
A new clinical trial for women with clinically aggressive triple-negative breast cancer (TNBC) will test a novel theory: Will a diet low in an essential nutrient make TNBC cells more vulnerable to cell killing by a new cancer ...
Oct 19, 2016
0
0
In a research study published in the journal Oncogene, scientists from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine showed that by therapeutically targeting the receptor for advanced ...
Oct 3, 2016
0
6
A new Tel Aviv University study finds that combining genetic therapy with chemotherapy delivered to a primary tumor site is extremely effective in preventing breast cancer metastasis.
Sep 19, 2016
0
33
The spread of malignant cells around the body, known as metastasis, is the leading cause of mortality in women with breast cancer.
Sep 19, 2016
0
291
A small device implanted under the skin can improve breast cancer survival by catching cancer cells, slowing the development of metastatic tumors in other organs and allowing time to intervene with surgery or other therapies.
Sep 15, 2016
0
371
When Hippocrates first described cancer around 400 B.C., he referred to the disease's telltale tumors as "karkinos"—the Greek word for crab. The "Father of Western Medicine" likely noted that cancer's creeping projections ...
Sep 13, 2016
0
104
An international team including Rice University researchers has discovered a way to fight the overexpression of a protein associated with the proliferation of breast cancer.
Sep 12, 2016
0
131
Individual cells within a tumor are not all the same. This may sound like a modern medical truism, but it wasn't very long ago that oncologists assumed that taking a single biopsy from a patient's tumor would be an accurate ...
Sep 9, 2016
0
3724
Scientists may have unlocked the genetic code that determines why many patients with estrogen receptor-positive breast cancer fail to respond to the widely used drug tamoxifen.
Sep 7, 2016
0
0
